APTX expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.981800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.285000E-01
Normal-vs-Stage2
9.231200E-01
Normal-vs-Stage3
1.915360E-01
Normal-vs-Stage4
4.209200E-01
Stage1-vs-Stage2
2.228200E-01
Stage1-vs-Stage3
1.899740E-02
Stage1-vs-Stage4
9.317800E-01
Stage2-vs-Stage3
6.282200E-02
Stage2-vs-Stage4
3.532600E-01
Stage3-vs-Stage4
7.065900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.688800E-01
Normal-vs-AfricanAmerican
5.900400E-01
Normal-vs-Asian
7.267200E-01
Caucasian-vs-AfricanAmerican
4.364400E-01
Caucasian-vs-Asian
5.925600E-01
AfricanAmerican-vs-Asian
6.689600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.383200E-01
Normal-vs-Female
9.229400E-01
Male-vs-Female
5.070600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.812000E-01
Normal-vs-Age(41-60Yrs)
7.853400E-01
Normal-vs-Age(61-80Yrs)
9.037400E-01
Normal-vs-Age(81-100Yrs)
5.630600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.431600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.176600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.978600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.524160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.245500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.889400E-01
Normal-vs-Daily Drinker
8.543400E-01
Normal-vs-Weekly Drinker
4.338200E-01
Normal-vs-Occasional Drinker
7.011600E-01
Normal-vs-Social Drinker
4.172600E-01
Non Drinker-vs-Daily Drinker
4.017400E-01
Non Drinker-vs-Weekly Drinker
3.442500E-03
Non Drinker-vs-Occasional Drinker
2.110000E-02
Non Drinker-vs-Social Drinker
2.861200E-03
Daily Drinker-vs-Weekly Drinker
1.704800E-01
Daily Drinker-vs-Occasional Drinker
3.055200E-01
Daily Drinker-vs-Social Drinker
1.362430E-01
Weekly Drinker-vs-Occasional Drinker
6.985400E-01
Weekly Drinker-vs-Social Drinker
9.046600E-01
Occasional Drinker-vs-Social Drinker
7.571200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.552800E-01
Normal-vs-Grade 2
8.678400E-01
Normal-vs-Grade 3
9.215800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.416000E-01
Grade 1-vs-Grade 3
3.967600E-01
Grade 1-vs-Grade 4
8.552800E-01
Grade 2-vs-Grade 3
3.481400E-01
Grade 2-vs-Grade 4
8.678400E-01
Grade 3-vs-Grade 4
9.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.949000E-01
Normal-vs-NonDiabetic
9.248400E-01
Diabetic-vs-NonDiabetic
7.922800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.959800E-01
Normal-vs-NoPancreatitis
9.429200E-01
Pancreatitis-vs-NoPancreatitis
9.651400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.640000E-01
Normal-vs-N1
9.634400E-01
N0-vs-N1
4.894600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.287000E-01
Normal-vs-TP53-NonMutant
9.640600E-01
TP53-Mutant-vs-TP53-NonMutant
8.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
